Empower-Lung 1: Phase Iii First-Line (1l) Cemiplimab Monotherapy Vs Platinum-Doublet Chemotherapy (Chemo) In Advanced Non-Small Cell Lung Cancer (Nsclc) With Programmed Cell Death-Ligand 1 (Pd-L1) >= 50%
Annals of Oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要